Erratum: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. [J Neuroinflammation. 13, (2016) (1)] DOI: 10.1186/s12974-016-0626-3

Catalina Abad; Bhavaani Jayaram; Laurine Becquet; Yuqi Wang; M. Sue O'Dorisio; James A. Waschek; Yossan Var Tan

ArticleOPEN ACCESS

Erratum: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. [J Neuroinflammation. 13, (2016) (1)] DOI: 10.1186/s12974-016-0626-3

Journal of Neuroinflammation

DOI: 10.1186/s12974-017-0927-1

3Citations

7Readers

Abstract

After publication of the article [1], it has been brought to our attention that one of the authors has had their name spelt incorrectly. The fourth author should be "Yuqi Wang". This has been updated in the original version of the article.

Cite

CITATION STYLE

APA

Abad, C., Jayaram, B., Becquet, L., Wang, Y., O’Dorisio, M. S., Waschek, J. A., & Tan, Y. V. (2017, August 4). Erratum: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. [J Neuroinflammation. 13, (2016) (1)] DOI: 10.1186/s12974-016-0626-3. Journal of Neuroinflammation. BioMed Central Ltd. https://doi.org/10.1186/s12974-017-0927-1

Erratum: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. [J Neuroinflammation. 13, (2016) (1)] DOI: 10.1186/s12974-016-0626-3

Abstract

Cite

Register to see more suggestions